Liminatus Pharma, Inc. (LIMNW) stock
LIMNWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as LIMN
$0.04+0.00 (0.00%)
Close on Oct 30, 2026Market cap $189.39MP/E –Yield –
Liminatus Pharma cash
Cash and short-term investments held at the end of each period.
Liminatus Pharma's cash was $3.02M at Jun 30, 2026. For fiscal 2025 it was $337.66K, up 499.5% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $337.66K | +499.5% |
| FY2024 | Dec 31, 2024 | $56.32K | – |
| FY2023 | Dec 31, 2023 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.02M | +125.5% |
| Q1 FY2026 | Mar 31, 2026 | $1.91M | – |
| Q4 FY2025 | Dec 31, 2025 | $337.66K | +499.5% |
| Q3 FY2025 | Sep 30, 2025 | $724.50K | – |
| Q2 FY2025 | Jun 30, 2025 | $1.34M | – |
| Q1 FY2025 | Mar 31, 2025 | $0 | – |
| Q4 FY2024 | Dec 31, 2024 | $56.32K | – |
| Q1 FY2024 | Mar 31, 2024 | $0 | – |
| Q4 FY2023 | Dec 31, 2023 | $0 | – |